|Articles|August 1, 1996

July/August 1996
Volume 2
Issue 7

Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

Author(s)Ronald H. Joe, PharmD, Catherine B. Carter, DPh

Download PDF: Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

Articles in this issue

over 29 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

over 29 years ago

Article

Correspondence regarding, "Ethics in Managed Care: The Obligation of Administration to Attending Consequences"

over 29 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

over 29 years ago

Article

Understanding the Behavioral Response to Medical Innovation

over 29 years ago

Article

Cost Comparison of Induction of Labor Versus Expectant Management in Pregnancies Lasting Longer Than 41 Weeks

over 29 years ago

Article

Respiratory Syncytial Virus Immune Globulin: A Cost-Effectiveness Analysis

over 29 years ago

Article

Improving Patient Satisfaction with Warfarin Management

over 29 years ago

Article

The Third Generation of Managed Care

over 29 years ago

Article

Results of a Smoking-Cessation Program in a Managed Care Setting

over 29 years ago

Article

Breast Cancer Screening: Who, When, and How

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD